# Sotera Health Co (SHC)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/sotera-health-co/ JSON: https://steadybase.io/company/sotera-health-co.json Checked Nov 10, 2026. Latest filing read: Nov 3, 2026.

## Company

- Legal name: Sotera Health Co
- Ticker: SHC (Nasdaq)
- SEC CIK: 0001822479
- Industry: Services-Misc Health & Allied Services, NEC (SIC 8090)
- Headquarters: Broadview Heights, OH
- Fiscal year ends: December 31
- SEC filer category: Large accelerated filer
- Website: soterahealth.com
- LinkedIn: https://www.linkedin.com/company/sotera-health-llc
- Next earnings date: Dec 2, 2026

## Key facts

- Revenue: $1.2B for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026). Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/0001822479-26-000015-index.html
- Operating income: $297.6M for the fiscal year ended Dec 31, 2024 (10-K filed Feb 27, 2025). Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247925000015/0001822479-25-000015-index.html
- Net income: $77.9M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026). Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/0001822479-26-000015-index.html
- SG&A: $252.8M for the fiscal year ended Dec 31, 2025 (10-K filed Feb 24, 2026). Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/0001822479-26-000015-index.html
- Employees: 3,000 as of Dec 31, 2025, as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm
- Shares outstanding: 285,630,846 as of Oct 27, 2026 (10-Q filed Nov 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000058/0001822479-26-000058-index.html
- Auditor: Ernst & Young LLP, Cleveland, Ohio, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm

## Business

We are a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry. We are driven by our mission: Safeguarding Global Health ® . We provide end-to-end sterilization as well as microbiological and analytical lab testing and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients and consumers in the United States and around the world.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $1.2B | n/a | $77.9M | $252.8M |
| Dec 31, 2024 | $1.1B | $297.6M | $44.4M | $242.6M |
| Dec 31, 2023 | $1.0B | $276.7M | $51.4M | $236.7M |
| Dec 31, 2022 | $1.0B | $248.3M | -$233.6M | $245.7M |
| Dec 31, 2021 | $931.5M | $256.7M | $116.9M | $198.2M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/sotera-health-co.json

## Officers and directors

- Alton Shader, Chief Executive Officer. Source: 8-K filed Nov 3, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000182247926000055/november32026-ex991.htm
- Jonathan M. Lyons, Sr. Vice President, CFO. Source: Form 4 filed Aug 7, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000119312526340288/0001193125-26-340288-index.htm
- Jonathan (Jon) Lyons, Senior Vice President and Chief Financial Officer. LinkedIn: https://www.linkedin.com/in/jonathan-lyons-a246576. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm
- Michael P. Rutz, President of Sterigenics. LinkedIn: https://linkedin.com/in/michael-rutz-2246596. Source: Form 4 filed Aug 11, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000119312526344757/0001193125-26-344757-index.htm
- Michael (Mike) P. Rutz, President of Sterigenics. LinkedIn: https://linkedin.com/in/michael-rutz-2246596. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm
- Erika Ostrowski, SVP, General Counsel and Sec.. LinkedIn: https://linkedin.com/in/erikaostrowski. Source: Form 3 filed Apr 8, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000119312526147592/0001193125-26-147592-index.htm
- Alexander (Alex) Dimitrief, Senior Vice President and General Counsel. Source: 10-K filed Feb 24, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm
- Michael B. Petras Jr., Executive Chairman. Source: Form 4 filed Aug 19, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000119312526356962/0001193125-26-356962-index.htm
- Alexander Dimitrief, Former SVP, GC and Sec.. Source: Form 4 filed Apr 2, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000119312526140422/0001193125-26-140422-index.htm
- Christopher A. Simon, Board member (per proxy). Source: DEF 14A filed Apr 8, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000110465926040937/tm261581-1_def14a.htm
- Jonathan Lyons, Board member (per proxy). LinkedIn: https://www.linkedin.com/in/jonathan-lyons-a246576. Source: DEF 14A filed Apr 8, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000110465926040937/tm261581-1_def14a.htm
- Sean L. Cunningham, Board member (per proxy). Source: DEF 14A filed Apr 8, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000110465926040937/tm261581-1_def14a.htm
- Vincent K. Petrella, Board member (per proxy). Source: DEF 14A filed Apr 8, 2026, https://www.sec.gov/Archives/edgar/data/1822479/000110465926040937/tm261581-1_def14a.htm

## Recent 8-K events

- Nov 3, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000055/shc-20261103.htm
- Aug 14, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000050/shc-20260811.htm
- Aug 6, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000044/shc-20260806.htm
- May 22, 2026: Item 5.07, Submission of matters to a vote of security holders. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000034/shc-20260521.htm
- May 20, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000119312526232585/d107933d8k.htm
- May 13, 2026: Item 1.02, Termination of a material definitive agreement; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000119312526221630/d113042d8k.htm
- May 5, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000028/shc-20260430.htm
- Mar 16, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000019/shc-20260312.htm
- Mar 6, 2026: Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000119312526096983/d76958d8k.htm
- Feb 24, 2026: Item 2.02, Results of operations and financial condition (earnings release); Item 5.02, Departure or appointment of directors or officers; compensation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000012/shc-20260218.htm

## Insider trades (Form 4)

- Aug 17, 2026: Michael B. Petras Jr. (Executive Chairman) sold 1,144,515 shares, about $21.2M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000119312526356962/0001193125-26-356962-index.htm
- Aug 7, 2026: Michael P. Rutz (President of Sterigenics) sold 150,000 shares, about $2.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000119312526344757/0001193125-26-344757-index.htm
- May 13, 2026: Pincus XI-C LLC Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus &. Co. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus Llc Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus Private Equity XI-C L.P. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus Partners GP LLC Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus Partners (Cayman) L.P. Warburg II (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus (Bermuda) Private Equity GP Ltd. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus (Cayman) XI L.P. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010903/0001999371-26-010903-index.htm
- May 13, 2026: Pincus XI L.P. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010899/0001999371-26-010899-index.htm
- May 13, 2026: Pincus &. Co. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010899/0001999371-26-010899-index.htm
- May 13, 2026: Pincus Private Equity XI L.P. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010899/0001999371-26-010899-index.htm
- May 13, 2026: XI Partners L.P. WP (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010899/0001999371-26-010899-index.htm
- May 13, 2026: Pincus Private Equity XI-B L.P. Warburg (Director) sold 19,102,952 shares, about $289.8M. Source: https://www.sec.gov/Archives/edgar/data/1822479/000199937126010899/0001999371-26-010899-index.htm

## What management said

- "We are pleased with our third-quarter performance, which included solid top- and bottom-line constant currency growth, along with nearly 100 basis points of sequential Adjusted EBITDA margin expansion" Alton Shader, Chief Executive Officer (8-K filed Nov 3, 2026). Source: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000055/november32026-ex991.htm

## Latest filings

- 8-K filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000055/shc-20261103.htm
- 10-K filed Feb 24, 2026: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000015/shc-20251231.htm
- 10-Q filed Nov 3, 2026: https://www.sec.gov/Archives/edgar/data/1822479/000182247926000058/shc-20260930.htm
- DEF 14A filed Apr 8, 2026: https://www.sec.gov/Archives/edgar/data/1822479/000110465926040937/tm261581-1_def14a.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/